Agios Pharmaceuticals, Inc. (FRA:8AP)

Germany · Delayed Price · Currency is EUR

24.20

+0.80 (3.42%)

At close: Jan 8, 2026

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	2009 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2009 - 2018
Medicines for Cellular Metabolism	36.50M	Log In	Log In	Log In	Log In	Upgrade
Medicines for Cellular Metabolism Growth	36.07%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	2009 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2009 - 2018
United States	36.50M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	36.07%	Log In	Log In	Log In	Log In	Upgrade